Search
Pharvaris NV
PHVSAdd to Watchlist
33.950USD
-0.630-1.82%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
2.22BMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-1.82%
5 Days
+1.98%
1 Month
+16.67%
6 Months
+22.34%
Year to Date
+22.34%
1 Year
+96.81%
Key Figures
34.580Open
34.580High
376.13KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.57%Turnover Ratio
34.580Prev. Close
33.220Low
9.68MTurnover
LossP/E Static
8.01P/B
0.00%Div Yield TTM
-66.38%ROA
33.33052wk High
0.59Volume Ratio
-100.88MNet Profit
65.42MShares
-2.3543EPS TTM
-2.35Beta
-73.02%ROE
15.51052wk Low
3.93%Amplitude
--Gross Margin
2.22BMarket Cap
4.93Reward/Risk
3.92%Risk Rate
TradingKey Stock Score
No stock score available due to insufficient data.
Pharvaris NV News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Pharvaris NV Info
Pharvaris NV is a Netherlands-based company primarily engaged in the biopharmaceutical industry. The Company focuses on developing oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks. Their key product is Deucrictibant (PHA121, PHA-022121), which is a small-molecule bradykinin B2 receptor antagonist. It is intended for both the on-demand and prophylactic treatment of HAE attacks. Deucrictibant has been studied in vitro, ex vivo, and in vivo models to assess its effectiveness in blocking the bradykinin B2 receptor. The Company is developing deucrictibant for on-demand use as PHVS416, a softgel capsule, and for prophylactic use as PHVS719, an extended-release tablet.
Ticker SymbolPHVS
CompanyPharvaris NV
CEOModig (Berndt B.A.E)
Websitehttps://pharvaris.com/
Related Instruments
-0.64%
-0.05%
-2.95%
-0.23%
-2.41%
-1.64%
-0.22%
+1.75%
-0.29%
-0.79%
+0.26%
-2.00%
-2.10%
-2.41%
+1.68%
0.00%
+0.19%
-1.97%
+0.06%
-0.44%Popular Instruments
FAQs
What is the current price of Pharvaris NV (PHVS)?
The current price of Pharvaris NV (PHVS) is 33.95.
What is the symbol of Pharvaris NV?
The ticker symbol of Pharvaris NV is PHVS.
What is the 52-week high of Pharvaris NV?
The 52-week high of Pharvaris NV is 33.33.
What is the 52-week low of Pharvaris NV?
The 52-week low of Pharvaris NV is 15.51.
What is the market capitalization of Pharvaris NV?
The market capitalization of Pharvaris NV is 2.22B.
Is Pharvaris NV (PHVS) currently rated as Buy, Hold, or Sell?
According to analysts, Pharvaris NV (PHVS) has an overall rating of Buy, with a price target of 46.93.
What is the Earnings Per Share (EPS TTM) of Pharvaris NV (PHVS)?
The Earnings Per Share (EPS TTM) of Pharvaris NV (PHVS) is -3.49.